Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
5-Year IF – 2.0, IF – 1.9, JCI (2024) – 0.43
Scopus CiteScore – 4.3
Q1 in SJR 2024, SJR score – 0.598, H-index: 49 (SJR)
ICV – 161.00; MNiSW – 70 pts
Initial editorial assessment and first decision within 24 h

ISSN 1899–5276 (print), ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2017, vol. 26, nr 4, July, p. 679–686

doi: 10.17219/acem/67150

PubMed ID: 28691429

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The effect of bariatric procedures on selected laboratory parameters of patients from rural areas in Poland

Regina Sierżantowicz1,A,C,D, Jolanta Lewko2,B,E, Lech Trochimowicz1,A,E,F, Bożena Kirpsza1,B,D, Jacek Dadan3,E,F, Hady Razak Hady3,A,C,E,F

1 Department of Surgical Nursing, Medical University of Bialystok, Poland

2 Department of Integrated Medical Care, Medical University of Bialystok, Poland

3 Department of General and Endocrine Surgery, Medical University of Bialystok, Poland

Abstract

Background. Rural areas in Poland are inhabited by over 15 million people, i.e. 39.5% of Polish population, including about 5 million rural residents in the Podlaskie province. The incidence of obesity is associated with increased prevalence of obesity-related conditions. Studies that have been conducted do not confirm the efficacy of conservative treatment of obesity, but show that bariatric procedures produce the best longterm results.
Objectives. The aim of the study was to present the effects of bariatric obesity treatments (laparoscopic adjustable gastric banding [LAGB], sleeve gastrectomy [SG], Roux-en-Y gastric bypass [RYGB]) on body mass index (BMI), selected diabetes control parameters, dyslipidemia, hepatic and renal enzymes, blood count and hypertension control.
Material and Methods. The study group comprised a total of 100 consecutive patients from rural areas qualified for bariatric procedures. Most of the patients (69.07%) underwent SG; 11.34% underwent LAGB; and 19.59% underwent RYGB. Comorbidities included hypertension (35%), type 2 diabetes (52%) and hyperlipidemia (15%). Glucose, insulin, HbA1C, alanine and aspartate aminotransferase, bilirubin, total and fraction cholesterol, creatinine, urea, uric acid and CRP levels, as well as blood count and blood pressure values, were assessed prior to surgery and during follow-up visits 3 and 6 months after the procedures. BMI, percentage of excess weight loss (%EWL) and percentage of excess body mass index loss (%EBMIL) were assessed.
Results. Consistent, significant decreases in BMI were observed 3 months (39.31 ± 4.70) and 6 months (35.74 ± 4.52) after surgery. The largest BMI reduction at the 6-month follow up was observed for SG (12.29%), and the smallest was observed for LAGB (9.02%).
Conclusion. Improvements in the general health status of the patients were observed, as well as normalization of metabolic parameters (glucose, cholesterol, triglycerides, hepatic enzymes).

Key words

obesity, bariatric surgery, remission, rural population, type 2 diabetes mellitus

References (36)

  1. World Health Organization. Obesity and Overweight. 2011. http://www.who.int/mediacentre/factsheets/fs311/en/print.html, 2011.
  2. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: A systematic review and meta-analysis. JAMA. 2004;292(14):1724–1737.
  3. Babińska Z, Trzeciak BG, Bandosz P, etal. Rozpowszechnienie nadwagi i otyłości w populacji wiejskiej- Program ,,Kiełpino”. Prim Care Rev. 2006;8:569–571.
  4. GUS. Ludność. Stan i struktura w przekroju terytorialnym. Stan w dniu 30.06.2013 r.
  5. Sullivan PW, Ghushchyan VH, Ben-Joseph R. The impact of obesity on diabetes, hyperlipidemia and hypertension in the United States. Qual Life Res. 2008;17(8):1063–1671. doi: 10.1007/s11136-008-9385-7.
  6. Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: Findings from the National Health and Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg. 2008;207(6):928–934. doi: 10.1016/j.jamcollsurg.2008.08.022.
  7. Gloy VL, Briel M, Bhatt DL, et.al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. BMI. 2013;347:f5934. doi: 10.1136/bmj.f5934
  8. Biter LU, Gadiot RP, Grotenhius BA, et al. The Sleeve Bypass Trial: A multicenter randomized controlled trial comparing the long-term outcome of laparoscopic sleeve gastrectomy and gastric bypass for morbid obesity in terms of excess BMI loss percentage and quality of life. BMC Obes. 2015;2:28.
  9. Toolabi K, Golzarand M, Farid R. Laparoscopic adjustable gastric banding: Efficacy and consequences over a 13-year period. Am J Surg. 2015 doi: 10.1016/j.amjsurg.2015.05.021.
  10. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012,26;366(17):1567–1576. doi: 10.1056/NEJMoa1200225.
  11. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577–1585.
  12. Raffaelli M, Guidone C, Callari C, et al. Effect of gastric bypass versus diet on cardiovascular risk factors. Ann Surg. 2014;259(4):694–699.
  13. Befort CA, Nazir N, Perri MG. Prevalence of obesity among adults from rural and urban areas of the United States: Findings From NHANES (2005–2008). J Rural Health 2012;28(4):392-397. doi:10.1111/j.1748-0361.2012.00411.x.
  14. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2014. Stanowisko Polskiego Towarzystwa Diabetologicznego. Clinical Diabetology. 2014; 3, supl. A.
  15. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care. 2004;27(6):1487–1495.
  16. Tykarski A, Grodzicki T. 2007 ESH/ESC Guidelines for the Management of Arterial Hypertension-what new? Attempt of commentary on changes and their validity. Arterial Hypertension. 2007;11(4):261–303.
  17. Chopra SM, Misra A, Gulati S, et al. Overweight, obesity and related non-communicable diseases in Asian Indian girls and women. Eur J Clin Nutr. 2013;67(7):688–696.
  18. Hu J, Si Y, Zhou D, et al. Prevalence and treatment gap of active convulsive epilepsy: A large community-based survey in rural West China. Seizure. 2014;17. doi: 10.1016/j.seizure.2014.01.007.
  19. Gajewska M, Goryński P, Wysocki MJ. Obesity and type 2 diabetes as main causes of hospitalization in Polish hospitals in 2008. Probl Hig Epidemiol. 2011;92(1):132–136.
  20. Abbatini F, Rizzello M, Casella G, et.al. Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc. 2010;24(5):1005–1010. doi: 10.1007/s00464-009-0715-9.
  21. Silecchia G, Boru C, Pecchia A, et al. Effectiveness of laparoscopic sleeve gastrectomy (first stage of biliopancreatic diversion with duodenal switch) on co-morbidities in super-obese high-risk patients. Obes Sur. 2006;16(9):1138–1144.
  22. Helmio M, Victorzon M, Ovasaka J. et al. Sleevepass: a randomized prospective multicenter study comparing laparoscopic sleeve gastrectomy and gastric bypass in the treatment of morbid obesity: preliminary results. Surg Endosc. 2012;26(9):2521–2526. doi: 10.1007/s00464-012-2225-4.
  23. Varel JE. Laparoscopic Sleeve Gastrectomy versus Laparoscopic Adjustable Gastric Banding for the treatment severe obesity in high risk patients. JSLS. 2011;15(4):486–491. doi:10.4293/108680811X13176.
  24. Nguyen NQ, Game P, Bessel J, et al. Outcomes of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding. World J Gastroenterol. 2013;19(36):6035–6043.
  25. Li JF, Lai DD, Lin ZH, et al. Comparison of the long-term results of Roux-en-Y gastric bypass and Sleeve Gastrectomy for morbid obesity: A systematic review and meta-analysis of randomized and nonrandomized trials. Surg Laparosc Endosc Percutan Tech. 2014;24(1):1–11.
  26. Paluszkiewicz R, Kalinowski P, Wróblewski T, et al. Prospective randomized clinical trial of laparoscopic sleeve gastrectomy versus open Roux-en-Y gastric bypass for the management of patients with morbid obesity. Videosurgery and other Miniinvasive Techniques. 2012;7(4):225–232. doi:10.5114/wiitm.2012.32384.
  27. Tice JA, Karliner L, Walsh J, et al. Gastric Banding or Bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885–893.
  28. Fred M, Hainer W, Basdevant A, et al. Interdisciplinary European guidelines on surgery of severe obesity. Obes Surg. 2007;17(2):260–270.
  29. Singh AK, Singh R, Kota SK. Bariatric surgery and diabetes remission: Who would have thought it? Indian J Endocrinol Metab. 2015;19(5):563–576.
  30. Musella M, Apers J, Rheinwalt K, et al. Efficacy of bariatric surgery in type 2 diabetes mellitus remission: The role of mini gastric bypass/one anastomosis gastric bypass and sleeve gastrectomy at 1 year of follow-up. A European survey. Obes Surg. 2015; DOI 10.1007/s11695-015-1865-6.
  31. Hady HR, Dadan J, Gołaszewski P. 100 obese patients after laparoscopic adjustable gastric banding-the influence on BMI, ghrelin and insulin concentration, parameters of lipid balance and co-morbidities. Adv Med Sci. 2012;57(1):58–64.
  32. Waldmann E, Hüttl TP, Göke B, et al. Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients. Lipids in Health and Disease. 2013;12:82.
  33. Al Khalifa K, Al Ansari A, Alsayed AR, et.al. The impact of Sleeve gastrectomy on hyperlipidemia: A systematic review. Journal of Obesity. 2013; Article ID 643530, 7 pages.
  34. Benaiges D, Flores-Le-Roux JA, Pedro-Botet J, et al. Impact of restrictive (Sleeve Gastrectomy) vs hybrid bariatric surgery (Roux-en-Y Gastric Bypass) on lipid profile. Obes Surg. 2012;22(8):1268–1275. doi: 10.1007/s11695-012-0662-8.
  35. Klein S, Mittendorfer B, Eagon JC, et al. Gastric Bypass Surgery improves metabolic and Hepatic Abnormalities associated with Nonalcoholic Fatty Liver Disease. Gastroenterology 2006;130(6):1564–1572.
  36. Maalouf NM, Tondapu P, Guth ES, et al. Hypocitaturia and hyperoxaluria after Roux-en-Y Gastric Bypass Surgery. J Urol. 2010;183(3):1026–1030. doi: 10.1016/j.juro.2009.11.022.
© Wroclaw Medical University